Microglial activation facilitates Aβ plaque removal following intracranial anti-Aβ antibody administration
- 11 December 2003
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 15 (1) , 11-20
- https://doi.org/10.1016/j.nbd.2003.09.015
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of PathogenesisScience, 2003
- Passage of amyloid β protein antibody across the blood–brain barrier in a mouse model of Alzheimer’s diseasePeptides, 2002
- Aβ immunization and anti-Aβ antibodies: potential therapies for the prevention and treatment of Alzheimer’s diseaseAdvanced Drug Delivery Reviews, 2002
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease modelNature Neuroscience, 2002
- Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivoNature, 2002
- Time Course of the Development of Alzheimer-like Pathology in the Doubly Transgenic PS1+APP MouseExperimental Neurology, 2002
- Biochemical detection of Aβ isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer’s diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2000
- Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's DiseaseThe American Journal of Pathology, 1999
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996